Faculty

AACSB Announces 2024 Class of Influential Leaders

Retrieved on: 
Monday, April 8, 2024
AI, Research, AACSB, Entrepreneurship, Academic Partnerships, Health, Faculty

TAMPA, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- AACSB International (AACSB)—the world’s largest business education alliance—announces today its 2024 Class of Influential Leaders , a group of 22 AACSB-accredited business school faculty demonstrating impact through their research.

Key Points: 
  • TAMPA, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- AACSB International (AACSB)—the world’s largest business education alliance—announces today its 2024 Class of Influential Leaders , a group of 22 AACSB-accredited business school faculty demonstrating impact through their research.
  • All faculty from this year’s class are from one of AACSB’s more than 1,000 accredited business schools worldwide.
  • “The 2024 Influential Leaders demonstrate the potential of business school research to address some of today’s most critical challenges,” said Lily Bi, AACSB president and CEO.
  • Support for the 2024 Influential Leaders initiative is provided by Academic Partnerships .

Genius Group launches AI Avatar Toolkit for Global Faculty to build their own AI Tutors

Retrieved on: 
Friday, April 5, 2024
Q&A, Enterprise portal, Education, Knowledge, Artificial intelligence, AI, Faculty, Student, Marketing, Evaluation, Book, Feedback, Customer service

SINGAPORE, April 05, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered education group, announced today the launch of its artificial intelligence (“AI”) Avatar Toolkit on its Edtech platform, GeniusU, enabling its global faculty of 15,000 education partners to build their own AI tutors and learning assistants to provide personalized, guided learning to their students.

Key Points: 
  • SINGAPORE, April 05, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered education group, announced today the launch of its artificial intelligence (“AI”) Avatar Toolkit on its Edtech platform, GeniusU, enabling its global faculty of 15,000 education partners to build their own AI tutors and learning assistants to provide personalized, guided learning to their students.
  • Following the successful launch of Genius Group’s AI Avatar Tutor Team, “Student AI”, and AI Avatar C-Suite “Genius Team AI” to its 5.4 million entrepreneur students on its Edtech platform, GeniusU, the Company is now providing all of its partners with the same AI-driven avatar-building tools.
  • Implement AI Avatars in Marketing:
    Explore innovative ways to incorporate AI Avatars into your marketing campaigns, enhancing customer interaction and engagement through personalized avatar-led experiences.
  • Evaluate and Optimize Avatar Performance:
    Master the skills to assess the effectiveness of AI Avatar interactions and optimize their performance for better customer engagement and business outcomes.

Token2049 Dubai Gears Up for Unmissable Social Event Hosted by Tobi and Brent

Retrieved on: 
Friday, April 5, 2024
Friends, Lock, Faculty, Kaisar, LP record, VCS, Work, Telegraphy, Cryptocurrency

Dubai UAE, April 05, 2024 (GLOBE NEWSWIRE) --  In true degen fashion, two friends have gathered the biggest organic group of the crypto community in the lead-up to Token2049 Dubai. Eponymously named “Token2049 Dubai with Tobi and Brent,” the Telegram group has rapidly grown to over 3000 members since its inception on March 13, 2024.

Key Points: 
  • Eponymously named “Token2049 Dubai with Tobi and Brent,” the Telegram group has rapidly grown to over 3000 members since its inception on March 13, 2024.
  • Known for their brutal anti-shilling approach, Tobi and Brent are taking steps to ensure the community spirit and mutual benefit of the group.
  • These self-proclaimed ‘bros’ are also set to host the biggest social side event of Token2049 Dubai.
  • I’ve created niche crypto communities in Singapore, Hong Kong, Bangkok, Denver, and NYC, and now we’re taking Dubai by storm.” commented Tobias Bauer (Tobi).

Correction: A Musical About Self-Discovery Through Music | NYFA 2024 New Works Show “Paper Valley” to Stir Audiences this April

Retrieved on: 
Thursday, April 4, 2024
Parade, Musical, Learning, Tootsie, Music supervisor, Environment, Chocolate Factory, Beauty, Somnolence, Almost Famous, Mystery, The Queen of Versailles, Faculty, NYFA, Kate Sullivan, Student, How to Dance, Beauty and the Beast, Love, Creativity, The Will Rogers Follies, Book of Mormon, Music, Jagged Little Pill, Musical theatre

The show is part of the school’s long-standing “New Works Series” and is open to the public.

Key Points: 
  • The show is part of the school’s long-standing “New Works Series” and is open to the public.
  • The emotional journey follows Kate as she faces old memories, tough truths, and self-discovery through music.
  • The 2024 “New Works Series” is a long-standing series of original works created and performed by the New York City campus students of the NYFA Musical Theatre department.
  • For those interested in learning about studying musical theatre at NYFA, check out the school's degrees, programs, short-term workshops, and teens and kids camps on the musical theatre discipline page .

Dr. Marra Francis Joins Genece Health as Chief Medical Officer

Retrieved on: 
Wednesday, April 3, 2024
Health, Obstetrics, Faculty, Gynaecology, Physician, FACOG, DEL, Memorial Hermann–Texas Medical Center, Lung, Breast, University, MD, Biology, Ovary, Cancer, Liquid biopsy, GeneDx, Occidental College

DEL MAR, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Genece Health, a molecular testing company focused on improving cancer detection for lung, breast, ovarian and other cancers, today announced that Marra Francis, MD, FACOG, has joined the company as its chief medical officer.

Key Points: 
  • DEL MAR, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Genece Health, a molecular testing company focused on improving cancer detection for lung, breast, ovarian and other cancers, today announced that Marra Francis, MD, FACOG, has joined the company as its chief medical officer.
  • Dr. Francis’ past experience also includes serving as head of medical affairs for women's health of Sema4 (now GeneDx); as executive medical director of EverlyWell; and as chief medical officer of Aspira Women's Health.
  • Dr. Francis holds a medical degree from the University of Connecticut Health Center and a bachelor of arts degree in biology from Occidental College.
  • “We are delighted to have Marra join our team at a very exciting time for Genece,” said Greg Gosch, CEO of Genece Heath.

Sono-Tek Welcomes Dr. Adeniyi Lawal to Board of Directors

Retrieved on: 
Wednesday, April 3, 2024
McGill University, MIT, International, Knowledge, Research, Science, University, Stevens Institute of Technology, GAF Materials Corporation, Faculty, Engineering, Student, Doctor of Philosophy, Catalysis, Chemical engineering, International Flavors & Fragrances, Medical device

MILTON, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, announced the election of Dr. Adeniyi Lawal to the Company’s Board of Directors effective today. Dr. Lawal is expected to eventually replace Dr. Donald F. Mowbray, the Board member with the most significant technical expertise, who has indicated that he may not stand for reelection and whose current term expires as of the Company’s next annual meeting of shareholders which is expected to be held in August 2024.

Key Points: 
  • MILTON, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, announced the election of Dr. Adeniyi Lawal to the Company’s Board of Directors effective today.
  • His core expertise is in catalysis, reaction engineering and process intensification with specific application to renewable energy, a core market for Sono-Tek.
  • Dr. Christopher L Coccio, Executive Chairman of Sono-Tek, said, “We welcome Dr. Lawal to the Board of Sono-Tek.
  • Dr. Lawal has also been active in scientific societies, and has organized and chaired national and international conferences.

Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives

Retrieved on: 
Tuesday, April 2, 2024
Moses Austin, Ohio State University, Edwards Lifesciences, Education, Patient, Global strategy, SVP, Coronary thrombosis, Business development, Radiology, University, Doctors Hospital, Faculty, Senior, Abstract, MD Anderson Cancer Center, Hospital, MitraClip, Baptist Hospital, Interventional radiology, Health, Global marketing

IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), today announced the appointment of Tim Benner as Senior Vice President of U.S.

Key Points: 
  • IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), today announced the appointment of Tim Benner as Senior Vice President of U.S.
  • Dr. Niekamp will be instrumental in advancing Inari’s mission to improve patient care through physician education and new device development.
  • Mr. Benner joins Inari with more than 16 years of senior leadership experience with high-growth and transformational medical technology companies.
  • We are honored to add his talents to our Medical Affairs team,” said Dr. Thomas Tu, Chief Medical Officer of Inari.

A Musical About Self-Discovery Through Music: NYFA 2024 New Works Show “Paper Valley” to Stir Audiences this April

Retrieved on: 
Tuesday, April 2, 2024
Parade, Musical, Learning, Tootsie, Music supervisor, Environment, Chocolate Factory, Beauty, Somnolence, Almost Famous, Mystery, Faculty, NYFA, Kate Sullivan, Student, How to Dance, Beauty and the Beast, Love, Creativity, The Will Rogers Follies, Book of Mormon, Music, Jagged Little Pill, Musical theatre

The show is part of the school’s long-standing “New Works Series” and is open to the public.

Key Points: 
  • The show is part of the school’s long-standing “New Works Series” and is open to the public.
  • The emotional journey follows Kate as she faces old memories, tough truths, and self-discovery through music.
  • The 2024 “New Works Series” is a long-standing series of original works created and performed by the New York City campus students of the NYFA Musical Theatre department.
  • For those interested in learning about studying musical theatre at NYFA, check out the school's degrees, programs, short-term workshops, and teens and kids camps on the musical theatre discipline page .

NBME Recognizes Dr. Karen Hauer with Prestigious Medical Education Research Award

Retrieved on: 
Tuesday, April 2, 2024
Medical education, Internal medicine, Education, UCSF, Communication, Learning, Science, International, Patient, Bias, Knowledge, Research, University, Doctor of Philosophy, Faculty, MD, Student, Thought, MBA, UCSF Medical Center, Habit, Stanford University, Feedback, Physician, Health, NBME, Nursing

PHILADELPHIA, April 02, 2024 (GLOBE NEWSWIRE) -- Karen Hauer, MD, PhD, was selected as the recipient of NBME’s 2024 John P. Hubbard Award in recognition of her significant contributions to the field of medical education research and assessment.

Key Points: 
  • PHILADELPHIA, April 02, 2024 (GLOBE NEWSWIRE) -- Karen Hauer, MD, PhD, was selected as the recipient of NBME’s 2024 John P. Hubbard Award in recognition of her significant contributions to the field of medical education research and assessment.
  • NBME President and CEO Peter Katsufrakis, MD, MBA, echoes her sentiments about past Hubbard Award recipients and expresses his support and admiration for Dr. Hauer and her accomplishments.
  • She is an active researcher in health professions education with a focus on competency-based medical education, workplace-based assessment, equity and coaching.
  • P. Hubbard Award recognizes individuals for their outstanding contributions to the pursuit of assessment excellence within medical education.

Autolus Therapeutics Announces Changes to its Board of Directors

Retrieved on: 
Monday, April 1, 2024
Cubist Pharmaceuticals, DBV Technologies, MB, Alnylam Pharmaceuticals, Harvard Medical School, University of Cambridge, Faculty, Imperial College London, Development, GSK plc, Biologics license application, Hematology, Patient, ALL, Merck, Bristol Myers Squibb, Marketing, Biogen, Doctor of Philosophy, Bates College, Oxford Biomedica, Sarepta Therapeutics, Pharmaceutical medicine, Therapy, Swedish Orphan Biovitrum, Royal college, FDA, BLA, Autoimmunity, Economics, Food, Pharmaceutical industry

John H. Johnson advised the Board of his decision to step down from his role as Chairman of the Board and Non-Executive Director.

Key Points: 
  • John H. Johnson advised the Board of his decision to step down from his role as Chairman of the Board and Non-Executive Director.
  • We wish John much success with his new projects,” said Dr. Christian Itin, Chief Executive Officer of Autolus.
  • He is currently a director of Alnylam Pharmaceuticals and chair of Dunad Therapeutics and Gulf of Maine Research Institute.
  • Mr. Bonney has served as a director with many companies previously including Celgene, Kaleido Biosciences, Magenta Therapeutics, Bristol Myers Squibb, Sarepta Therapeutics and Syros Pharmaceuticals.